BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29896920)

  • 1. Decrease in eosinophilia as a marker of response to therapy in solid organ transplant candidates with Strongyloides infection: A single-center experience.
    Simkins J; Anjan S; Camargo JF
    Transpl Infect Dis; 2018 Oct; 20(5):e12954. PubMed ID: 29896920
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
    Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
    Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.
    Leung V; Al-Rawahi GN; Grant J; Fleckenstein L; Bowie W
    Am J Trop Med Hyg; 2008 Dec; 79(6):853-5. PubMed ID: 19052292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of Strongyloides hyperinfection syndrome in the setting of persistent eosinophilia but negative serology.
    Osiro S; Hamula C; Glaser A; Rana M; Dunn D
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):168-170. PubMed ID: 28377165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late post-kidney transplant Strongyloides hyperinfection syndrome.
    Nishio Lucar A; Knicely DH; Sifri CD
    Transpl Infect Dis; 2018 Dec; 20(6):e12975. PubMed ID: 30107075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].
    Manrique-Rodríguez S; Martín-Rabadán P; Díaz-Cámara M; Fernández-Llamazares CM
    Med Clin (Barc); 2016 Apr; 146(8):376-7. PubMed ID: 26654554
    [No Abstract]   [Full Text] [Related]  

  • 7. An elderly man with immunosuppression, shortness of breath, and eosinophilia.
    Abdalla J; Saad M; Myers JW; Moorman JP
    Clin Infect Dis; 2005 May; 40(10):1464, 1535-6. PubMed ID: 15846856
    [No Abstract]   [Full Text] [Related]  

  • 8. Type 2 Diabetes Mellitus Is Associated with Strongyloides stercoralis Treatment Failure in Australian Aboriginals.
    Hays R; Esterman A; McDermott R
    PLoS Negl Trop Dis; 2015; 9(8):e0003976. PubMed ID: 26295162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strongyloides stercoralis hyperinfection in an immunocompetent patient with extreme eosinophilia.
    Marathe A; Date V
    J Parasitol; 2008 Jun; 94(3):759-60. PubMed ID: 18605792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic oophoritis: association with positive Strongyloides stercoralis serology and clinical response to ivermectin.
    Butterfield JH; Kephart GM; Frankson JL
    J Pediatr Adolesc Gynecol; 2006 Oct; 19(5):329-32. PubMed ID: 17060015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ivermectin on allergy-type manifestations in occult strongyloidiasis.
    Rampur L; Jariwala SP; Hudes G; Rosenstreich DL; de Vos G
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):423-428. PubMed ID: 27566864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-Derived Strongyloidiasis Infection in Solid Organ Transplant Recipients: A Review and Pooled Analysis.
    Kim JH; Kim DS; Yoon YK; Sohn JW; Kim MJ
    Transplant Proc; 2016 Sep; 48(7):2442-2449. PubMed ID: 27742318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight loss · diarrhea · mild eosinophilia · Dx?
    Alqarawi WA; Khan KM; Bierman AS
    J Fam Pract; 2015 Mar; 64(3):174-6. PubMed ID: 25789350
    [No Abstract]   [Full Text] [Related]  

  • 14. Donor-derived strongyloidiasis after organ transplantation in Norway.
    Nordheim E; Olafsson Storrø M; Natvik AK; Birkeland Kro G; Midtvedt K; Varberg Reisaeter A; Hagness M; Fevang B; Pettersen FO
    Transpl Infect Dis; 2019 Feb; 21(1):e13008. PubMed ID: 30295406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of Strongyloides stercoralis through transplantation of solid organs--Pennsylvania, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Apr; 62(14):264-6. PubMed ID: 23575239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of severe strongyloidiasis attended at reference centers in Spain.
    Martinez-Perez A; Roure Díez S; Belhassen-Garcia M; Torrús-Tendero D; Perez-Arellano JL; Cabezas T; Soler C; Díaz-Menéndez M; Navarro M; Treviño B; Salvador F;
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006272. PubMed ID: 29474356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.
    Bogoch II; Khan K; Abrams H; Nott C; Leung E; Fleckenstein L; Keystone JS
    Am J Trop Med Hyg; 2015 Jul; 93(1):94-6. PubMed ID: 25918215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary strongyloidiasis.
    Jayaprakash B; Sandhya S; Anithakumari K
    J Assoc Physicians India; 2009 Jul; 57():535-6. PubMed ID: 20329418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Strongyloides stercoralis Hyperinfection in a Kidney Transplant Recipient: Case Report.
    Rego Silva J; Macau RA; Mateus A; Cruz P; Aleixo MJ; Brito M; Alcobia A; Oliveira C; Ramos A
    Transplant Proc; 2018 Apr; 50(3):861-866. PubMed ID: 29661454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia.
    Salvador F; Sulleiro E; Sánchez-Montalvá A; Saugar JM; Rodríguez E; Pahissa A; Molina I
    Am J Trop Med Hyg; 2014 May; 90(5):830-4. PubMed ID: 24615124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.